Y M Rustum
- Topics
- Colorectal Cancer Treatments and Studies (14 papers)Cancer therapeutics and mechanisms (10 papers)Biochemical and Molecular Research (9 papers)
- Journals
- Journal of Clinical OncologyJNCI Journal of the National Cancer InstituteJournal of Pharmacology and Experimental Therapeutics
- Partner nations
- United StatesItalyGermany
In The Last Decade
Y M Rustum
29 papers receiving 870 citations
Peers
Comparison fields: 5 of 93
- Oncology 509
- Molecular Biology 435
- Pulmonary and Respiratory Medicine 120
- Cancer Research 95
- Biomaterials 82
Countries citing papers authored by Y M Rustum
This map shows the geographic impact of Y M Rustum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y M Rustum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y M Rustum more than expected).
Fields of papers citing papers by Y M Rustum
This network shows the impact of papers produced by Y M Rustum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y M Rustum. The network helps show where Y M Rustum may publish in the future.
Co-authorship network of co-authors of Y M Rustum
This figure shows the co-authorship network connecting the top 25 collaborators of Y M Rustum. A scholar is included among the top collaborators of Y M Rustum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y M Rustum. Y M Rustum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | Overexpression of Bax enhances antitumor activity of chemotherapeutic agents in human head and neck squamous cell carcinoma. | 39 |
| 3 | 11 | |
| 4 | Dimerization of mitochondrial Bax is associated with increased drug response in Bax-transfected A253 cells. | 16 |
| 5 | Modeling of the time-dependency of in vitro drug cytotoxicity and resistance. | 89 |
| 6 | Topoisomerase-I inhibitor SN-38 can induce DNA damage and chromosomal aberrations independent from DNA synthesis. | 40 |
| 7 | Cellular determinants of resistance to indolocarbazole analogue 6-N-formylamino-12,13-dihydro-1,11-dihydroxy-13(beta-D-glucopyranosyl)- 5H-indolo[2,3-alpha]pyrrolo[3,4-c]carbazole-5,7(6H)-dione (NB-506), a novel potent topoisomerase I inhibitor, in multidrug-resistant human tumor cells. | 5 |
| 8 | 21 | |
| 9 | 28 | |
| 10 | 162 | |
| 11 | 32 | |
| 12 | DNA damage and p53 induction do not cause ZD1694-induced cell cycle arrest in human colon carcinoma cells. | 51 |
| 13 | Attenuation of the antitumor activity of 5-fluorouracil by (R)-5-fluoro-5,6-dihydrouracil. | 58 |
| 14 | 34 | |
| 15 | 2 | |
| 16 | Collateral sensitivity of human melanoma multidrug-resistant variants to the polyamine analogue, N1,N11-diethylnorspermine. | 14 |
| 17 | 15 | |
| 18 | Quantitation of dihydrofolate reductase and thymidylate synthase mRNAs in vivo and in vitro by polymerase chain reaction. | 19 |
| 19 | 7 | |
| 20 | Inhibition of tumor cell growth in vitro and in vivo by 1-beta-D-arabinofuranosylcytosine entrapped within phospholipid vesicles. | 70 |
About Y M Rustum
Y M Rustum is a scholar working on Oncology, Toxicology and Molecular Biology, having authored 29 papers that have together received 900 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (14 papers), Cancer therapeutics and mechanisms (10 papers) and Biochemical and Molecular Research (9 papers). The work is most often cited by research in Oncology (509 citations), Molecular Biology (435 citations) and Cancer Research (95 citations). Y M Rustum has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include E. Mayhew, William R. Greco, Shu Cao, U. Vanhoefer, A. Harstrick, S. Seeber, H. Wilke, Ming Yin, Harry K. Slocum and Shousong Cao. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.